Is praluent a biologic?

Is Praluent (alirocumab) a biologic drug?

Yes. Praluent (alirocumab) is a biologic medicine because it is a monoclonal antibody. Monoclonal antibodies are produced using biological systems and are typically classified as biologics rather than small-molecule drugs.

Is Praluent a “biologic” in the way insulin or vaccines are?

They’re similar in classification but not the same kind of biologic. Insulin is also made through biological processes but is a different type of product, while vaccines are designed to trigger immune responses. Praluent specifically acts as a monoclonal antibody targeted to lower LDL cholesterol.

What category does Praluent fall under?

Praluent is an antibody therapy used for lipid lowering, typically described in labeling and medical references as a monoclonal antibody (a type of biologic). If you’re comparing it to other cholesterol drugs, most common oral options (like statins) are small molecules, while Praluent is not.

Source

1. DrugPatentWatch.com - Praluent (alirocumab) details